Mia's Feed
Medical News & Research

Supporting Vaping Cessation: Strategies for Those Quitting Nicotine Vapes

Supporting Vaping Cessation: Strategies for Those Quitting Nicotine Vapes

Share this article

Learn about effective strategies and support systems to help individuals quit nicotine vaping, addressing the rising demand for cessation assistance in New Zealand and beyond.

2 min read

As several countries, including New Zealand, promote vaping (the use of e-cigarettes) as a tool to help individuals quit smoking tobacco, there's an increasing number of people trying to stop vaping nicotine now. Nicotine vapes can be addictive, and while they've assisted many in quitting cigarettes, others—including those who never smoked—are now seeking ways to quit vaping itself.

Recent surveys of over 1,000 nicotine vapers in Aotearoa New Zealand reveal that many face challenges similar to those encountered in traditional smoking cessation. Around 718 respondents had already quit vaping, while 401 still vaped, with some never having smoked tobacco. Higher dependence was associated with longer vaping duration and higher nicotine concentrations.

Common reasons for quitting include health concerns, the desire to cut dependence, and vaping costs. These motivations resemble those of cigarette quitters, emphasizing that many vapers aim to free themselves from nicotine addiction regardless of their initial reasons.

People employ various cessation strategies such as abrupt quitting ('cold turkey'), gradually reducing nicotine intake with patches, gums, or lozenges, and seeking support from family and friends. These methods mirror smoking cessation techniques. Despite some successfully quitting without difficulty, many others report stress, withdrawal symptoms, and social triggers—like being around others who vape—as relapse factors. These challenges are consistent across demographic groups and regardless of their initial reasons for vaping.

The study suggests existing smoking cessation tools—behavioral support, stress management, and tapering schedules—could be adapted to support vaping cessation more effectively. Special attention may be needed for younger populations or non-smokers who start vaping without prior tobacco use.

Vaping should continue to be offered as a harm reduction tool for current smokers, ideally as a short-term step-down process over 3–12 months to prevent relapse to smoking. However, given the rise in vaping among never-smokers, tailored support for quitting vaping is increasingly vital. The development of targeted cessation programs and ongoing clinical trials aim to address this challenge.

In summary, combining behavioral strategies, medical support, and social encouragement can improve success rates in quitting vaping. Recognizing the addictive nature of nicotine and the social triggers involved is crucial to designing effective cessation interventions for this growing demographic.

source: https://medicalxpress.com/news/2025-07-aid-people-vaping-nicotine-strategies.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Advancements in Seizure Localization Using ChatGPT Enhance Neurosurgical Precision

Innovative use of ChatGPT enhances the accuracy of identifying seizure origins in the brain, supporting neurosurgeons and improving epilepsy surgical outcomes.

The Impact of Late Meal Timing on Glucose Metabolism and Health

Emerging research indicates that eating late in the day can impair glucose metabolism and increase health risks, highlighting the importance of aligning meal times with our biological clocks.

Eight Babies Successfully Born Using Mitochondrial Donation Technique to Prevent Mitochondrial DNA Diseases

New treatment using mitochondrial donation technique has successfully resulted in eight healthy births, reducing the risk of inheriting mitochondrial DNA diseases. This breakthrough offers hope for affected families and marks a significant advancement in reproductive medicine.